The investigators randomly assigned participants in a double-blind, 1:1 fashion to receive rosuvastatin 10 mg daily (n = 1,391) or placebo (n = 1,385). Despite markedly reducing lipid levels ...
Dosing a statin (rosuvastatin) every other day (EOD) may provide significant lipoprotein changes while avoiding common adverse effects in this statin-intolerant population. Objective: To determine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback